Scarica l'app Stockscreener
4.29
6.45%
0.26
Dopo l'orario di chiusura:
4.29
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.03%
4.774
|
5.8964 | 5.1796 | 5.4085 | 5.732 |
| Depreciation and Amortization |
0.00%
0.00457
|
0.00457 | - | - | - |
| Operating Income/Loss |
19.03%
-4.774
|
-5.8964 | -5.1796 | -5.4085 | -5.732 |
| Income/Loss From Continuing Operations Before Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
| Income/Loss From Continuing Operations After Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
|
Net Income/Loss
|
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
| Diluted Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
| Basic Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
| Diluted Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.14%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):